SPX3,647.29-7.75 -0.21%
DIA291.30-1.42 -0.49%
IXIC10,829.50+26.58 0.25%

-- ImmunoPrecise Brief: Recorded Q1 FY23 Net Loss of US$9.4 Million, Vs Net Loss of $3.2 Million a Year Earlier

-- ImmunoPrecise Brief: Recorded Q1 FY23 Net Loss of US$9.4 Million, Vs Net Loss of $3.2 Million a Year Earlier

MT Newswires · 09/14/2022 04:14

Please log in to view news